MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...

One day after MEI Pharma rejected an unsolicited bid from investors Anson Funds Management and Cable Car Capital to take the company private, CEO Daniel P. Gold, PhD left effective immediately. Gold, ...

MEI Pharma Inc has a consensus price target of $22.27 based on the ratings of 7 analysts. The high is $80 issued by Brookline Capital on May 23, 2023. The low is $0.1 issued by Jefferies on ...

MEI Pharma may already have a merger lined up with Infinity Pharmaceuticals, but another suitor has emerged from the fray. MEI Pharma announced Tuesday evening it has received a proposal from ...

An update from MEI Pharma ( (MEIP) ) is now available.

SAN DIEGO, April 11, 2024--MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care ...

MEI Pharma's clinical development pipeline also includes ME-401, a highly differentiated oral PI3K delta inhibitor currently in a Phase Ib study in patients with relapsed/refractory CLL or ...

MEI Pharma, Inc. is a pharmaceutical company specializing in the development of innovative cancer therapies, focusing on acquiring and advancing promising cancer agents through strategic ...

MEI Pharma Conference Call and Webcast MEI will host an investor and analyst webcast event today, November 30, 2021, at 8:00 AM Eastern Time to review the TIDAL phase 2 study data reported today ...

MEI Pharma had cash and cash equivalents of $36.2 million as of March 31, 2018. It was anticipating at first that its cash would be enough until the 1st half of its calendar 2019.

MEI Pharma, Inc. MEIP was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a ...